Skip to content
Bending the Curve Trial by Trial
?

Author of the 1953 report of busulfan (Myleran) treatment in chronic myeloid leukaemia

D. A. G. Galton

Author of the 1953 Lancet paper titled "Myleran in chronic myeloid leukaemia; results of treatment". The 2003 US Myleran label states that the activity of busulfan in chronic myelogenous leukemia was first reported by D.A.G. Galton in 1953.

Sources

  1. GALTON DA. Myleran in chronic myeloid leukaemia; results of treatment. Lancet. 1953;264(6753):208-13.

    PubMedDOI

  2. U.S. Food and Drug Administration. Myleran (busulfan) 2-mg scored tablets: prescribing information, GlaxoSmithKline, 2003 (NDA 009386, supplement 23, 24 December 2003).

    Source